Wauwatosa, WI, United States of America

Krishnaswamy Narayanan

This inventor holds 5 USPTO granted patents. Top assignee: The Medical College of Wisconsin, Inc.. Active years: 1994-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1994-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Krishnaswamy Narayanan

Introduction

Krishnaswamy Narayanan is a notable inventor based in Wauwatosa, WI (US). He has made significant contributions to the field of medical science, particularly in the development of compounds that have therapeutic applications. With a total of 5 patents to his name, his work focuses on innovative solutions for treating various health conditions.

Latest Patents

Narayanan's latest patents include groundbreaking research on heme binding compounds and their use as inhibitors of nitric oxide formation from arginine. These compounds are particularly useful for treating hypotension, inflammation, and stroke. They aim to restore vascular contractile sensitivity to the effects of α1-adrenergic agonists. The compounds he has developed include Nδ-substituted ornithine or Nε-substituted lysine moieties, which have specific chemical structures designed for physiological activity.

Career Highlights

Narayanan is affiliated with the Medical College of Wisconsin, Inc., where he continues to advance his research. His work has garnered attention for its potential impact on medical treatments and patient care. His innovative approach to addressing complex health issues showcases his dedication to improving medical science.

Collaborations

One of his notable collaborators is Owen W Griffith, with whom he has worked on various projects. Their partnership has contributed to the advancement of research in their field.

Conclusion

Krishnaswamy Narayanan's contributions to medical science through his patents and research highlight his role as an influential inventor. His work continues to pave the way for innovative treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…